A carregar...
Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial
BACKGROUND: Currently, there are no established pharmacotherapies for cannabis use disorders (CUDs). As a long-acting alpha-2-adrenergic receptor agonist, guanfacine extended-release (G-XR) could be useful in the treatment of CUDs by mitigating withdrawal and improving behavioral control. OBJECTIVES...
Na minha lista:
| Publicado no: | Am J Drug Alcohol Abuse |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6949416/ https://ncbi.nlm.nih.gov/pubmed/31339797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2019.1620259 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|